Vivalavita Pharmaceuticals Private Limited, a active private limited company, was established on 23 February 2012 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52311MH2012PTC227367. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ajay Amerlal Melwani (Director), Ayush Ajay Melwani (Director). Past directors included Ayush Ajay Melwani, Neeraj Maniyar. It holds no open charges and ₹2.10 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 301, Sainara, 21 North Avenue, Linking Road Junction,Santacruz (West), Mumbai, Maharashtra, 400054.
U52311MH2012PTC227367
227367
23 February 2012
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Vivalavita Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Amerlal Melwani | Director | 23 Feb 2012 | Current |
| Ayush Ajay Melwani | Director | 07 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 09 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vivalavita Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 182.52% increase. The company also saw a substantial improvement in profitability, with a 181.47% increase in profit. The company's net worth moved up by a moderate rise of 7.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Vivalavita Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹21,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2012 | Icici Bank Limited | ₹2.10 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vivalavita Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vivalavita Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivalavita Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vivalavita Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Vivalavita Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Ayush Ajay Melwani was appointed as a Director was appointed as a Director on 07 Sep 2018 & has been associated with this company since 7 years 2 months . was documented.
A charge registered on 22 Mar 2012 via Charge ID 10342533 with Icici Bank Limited was fully satisfied on 20 Sep 2016. was recorded as a recent event.
The activity A charge with Icici Bank Limited amounted to Rs. 21.00 M with Charge ID 10342533 was registered on 22 Mar 2012. was completed.
The activity Ajay Amerlal Melwani was appointed as a Director was appointed as a Director on 23 Feb 2012 & has been associated with this company since 13 years 9 months . was completed.
The CIN of Vivalavita Pharmaceuticals Private Limited is U52311MH2012PTC227367.
Vivalavita Pharmaceuticals Private Limited is headquartered at 301, Sainara, 21 North Avenue, Linking Road Junction,Santacruz (West), Mumbai, Maharashtra, 400054.
Vivalavita Pharmaceuticals Private Limited was incorporated on 23 February 2012.
The current directors of Vivalavita Pharmaceuticals Private Limited are
The primary industry of Vivalavita Pharmaceuticals Private Limited is Trade.
Vivalavita Pharmaceuticals Private Limited is unlisted.
The authorized capital of Vivalavita Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Vivalavita Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX